Suchergebnisse - "Specchia, Giorgina"

PubPharm (24)

1

Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

enthalten in: The New England journal of medicine | 2024

von Sonneveld, P. | Dimopoulos, M. | Boccadoro, M. | +141

CommentIn: N Engl J Med. 2024 Apr 18;390(15):1440. - PMID 38631009

2

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia : an open-label, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lübbert, M. | Wijermans, P. | Kicinski, M. | +83

CommentIn: Lancet Haematol. 2023 Nov;10(11):e866-e867. - PMID 37914474

3

Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission

enthalten in: The New England journal of medicine | 2020

von Wei, A. | Döhner, H. | Pocock, C. | +127

CommentIn: Nat Rev Clin Oncol. 2021 Mar;18(3):132. - PMID 33462426

4

Impact of the type of anthracycline and of stem cell transplantation in younger patients with acute myeloid leukaemia : Long-term follow up of a phase III study

enthalten in: American journal of hematology | 2020

von Baron, F. | Efficace, F. | Cannella, L. | +25

5

A randomized double-blind trial of 3 aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia

enthalten in: Blood | 2020

von Rocca, B. | Tosetto, A. | Betti, S. | +29

CommentIn: Blood. 2020 Jul 9;136(2):151-153. - PMID 32645166

6

Autologous haematopoietic stem-cell transplantation versus bortezomib-melphalan-prednisone, with or without bortezomib-lenalidomide-dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95) : a multicentre, randomised, open-label, phase 3 study

enthalten in: The Lancet. Haematology | 2020

von Cavo, M. | Gay, F. | Beksac, M. | +57

CommentIn: Lancet Haematol. 2020 Jun;7(6):e427-e429. - PMID 32359505

7

The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design : Implementation of the serum thromboxane B2 assay as an evaluation tool of different aspirin dosing regimens in the clinical setting

enthalten in: Blood cancer journal | 2018

von De Stefano, V. | Rocca, B. | Tosetto, A. | +30

8

Randomized phase III trial of retinoic acid and arsenic trioxide versus retinoic acid and chemotherapy in patients with acute promyelocytic leukemia : health-related quality-of-life outcomes

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Efficace, F. | Mandelli, F. | Avvisati, G. | +16

CommentIn: J Clin Oncol. 2015 Mar 20;33(9):1090-1. - PMID 25691667

9

Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients

enthalten in: American journal of hematology | 2014

von Foà, R. | Del Giudice, I. | Cuneo, A. | +37

10

Results of a multicenter, controlled, randomized clinical trial evaluating the combination of piperacillin/tazobactam and tigecycline in high-risk hematologic patients with cancer with febrile neutropenia

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2014

von Bucaneve, G. | Micozzi, A. | Picardi, M. | +23

CommentIn: J Clin Oncol. 2014 Dec 1;32(34):3899. - PMID 25225417